サマリー

性感染症（STD）検査の世界市場 2023-2027
Technavioは性感染症（STD）検査市場を監視しており、2023年から2027年の間に29988.27百万ドル、予測期間中にCAGR5.46％で加速して成長すると予測しています。当レポートでは、性感染症（STD）検査市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、STDの有病率の増加、有利な償還政策の存在、世界各国の政府によるイニシアチブの増加によって牽引されています。
Technavioの性感染症（STD）検査市場は、以下のように区分されています。
疾患タイプ別
- クラミジア
- 淋病
- 梅毒
- トリコモナス症
- その他
製品別
- ラボ用検査機器
- POC検査装置
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域(ROW)
本調査では、今後数年間の性感染症（STD）検査市場の成長を促進する主な理由の一つとして、STDの迅速診断の進歩を挙げています。また、STDと迅速パートナー療法（EPT）についての意識を高めるための様々な組織の関与の増加は、市場における相当な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。性感染症（STD）検査市場に関する当レポートは、以下の分野を対象としています。
- 性感染症（STD）検査市場のサイジング
- 性感染症（STD）検査市場の予測
- 性感染症（STD）検査市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、アキュバイオテック株式会社、AdvaCare Pharma Ltd.など、複数の性感染症（STD）検査市場の主要ベンダーについて詳細に分析しています。Ltd.、AdvaCare Pharma、BIOGENIX Inc.Ltd.、CTK Biotech Inc.、Everlywell Inc.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、GlaxoSmithKline Plc、Goffin Molecular Technologies、Hangzhou Biotest Biotech Co.Ltd.、Hologic Inc.、Inovio Pharmaceuticals Inc.、Johnson and Johnson、LT Labs、Merck and Co.Inc.、OK Biotech Co.Ltd.、Priority STD Testing、QIAGEN NV、RayBiotech Life Inc.の7社です。また、性感染症（STD）検査市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sexually-transmitted-disease-std-testing-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global sexually transmitted disease (STD) testing market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global sexually transmitted disease (STD) testing market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Disease type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Disease Type
o 6.1 Market segments
o Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)
o 6.2 Comparison by Disease Type
o Exhibit 32: Chart on Comparison by Disease Type
o Exhibit 33: Data Table on Comparison by Disease Type
o 6.3 Chlamydia - Market size and forecast 2022-2027
o Exhibit 34: Chart on Chlamydia - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Chlamydia - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Chlamydia - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Chlamydia - Year-over-year growth 2022-2027 (%)
o 6.4 Gonorrhea - Market size and forecast 2022-2027
o Exhibit 38: Chart on Gonorrhea - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Gonorrhea - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Gonorrhea - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Gonorrhea - Year-over-year growth 2022-2027 (%)
o 6.5 Syphilis - Market size and forecast 2022-2027
o Exhibit 42: Chart on Syphilis - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Syphilis - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Syphilis - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Syphilis - Year-over-year growth 2022-2027 (%)
o 6.6 Trichomoniasis - Market size and forecast 2022-2027
o Exhibit 46: Chart on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Trichomoniasis - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Trichomoniasis - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Disease Type
o Exhibit 54: Market opportunity by Disease Type ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 55: Chart on Product - Market share 2022-2027 (%)
o Exhibit 56: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 57: Chart on Comparison by Product
o Exhibit 58: Data Table on Comparison by Product
o 7.3 Laboratory testing device - Market size and forecast 2022-2027
o Exhibit 59: Chart on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Laboratory testing device - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Laboratory testing device - Year-over-year growth 2022-2027 (%)
o 7.4 POC testing device - Market size and forecast 2022-2027
o Exhibit 63: Chart on POC testing device - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on POC testing device - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on POC testing device - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 67: Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 116: AbbVie Inc. - Overview
o Exhibit 117: AbbVie Inc. - Product / Service
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 AccuBioTech Co. Ltd.
o Exhibit 119: AccuBioTech Co. Ltd. - Overview
o Exhibit 120: AccuBioTech Co. Ltd. - Product / Service
o Exhibit 121: AccuBioTech Co. Ltd. - Key offerings
o 12.5 AdvaCare Pharma
o Exhibit 122: AdvaCare Pharma - Overview
o Exhibit 123: AdvaCare Pharma - Product / Service
o Exhibit 124: AdvaCare Pharma - Key offerings
o 12.6 BIOGENIX Inc. Pvt. Ltd.
o Exhibit 125: BIOGENIX Inc. Pvt. Ltd. - Overview
o Exhibit 126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
o Exhibit 127: BIOGENIX Inc. Pvt. Ltd. - Key offerings
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 Gilead Sciences Inc.
o Exhibit 133: Gilead Sciences Inc. - Overview
o Exhibit 134: Gilead Sciences Inc. - Product / Service
o Exhibit 135: Gilead Sciences Inc. - Key news
o Exhibit 136: Gilead Sciences Inc. - Key offerings
o 12.9 GlaxoSmithKline Plc
o Exhibit 137: GlaxoSmithKline Plc - Overview
o Exhibit 138: GlaxoSmithKline Plc - Business segments
o Exhibit 139: GlaxoSmithKline Plc - Key offerings
o Exhibit 140: GlaxoSmithKline Plc - Segment focus
o 12.10 Hologic Inc.
o Exhibit 141: Hologic Inc. - Overview
o Exhibit 142: Hologic Inc. - Business segments
o Exhibit 143: Hologic Inc. - Key news
o Exhibit 144: Hologic Inc. - Key offerings
o Exhibit 145: Hologic Inc. - Segment focus
o 12.11 Inovio Pharmaceuticals Inc.
o Exhibit 146: Inovio Pharmaceuticals Inc. - Overview
o Exhibit 147: Inovio Pharmaceuticals Inc. - Product / Service
o Exhibit 148: Inovio Pharmaceuticals Inc. - Key news
o Exhibit 149: Inovio Pharmaceuticals Inc. - Key offerings
o 12.12 Johnson and Johnson
o Exhibit 150: Johnson and Johnson - Overview
o Exhibit 151: Johnson and Johnson - Business segments
o Exhibit 152: Johnson and Johnson - Key news
o Exhibit 153: Johnson and Johnson - Key offerings
o Exhibit 154: Johnson and Johnson - Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 155: Merck and Co. Inc. - Overview
o Exhibit 156: Merck and Co. Inc. - Business segments
o Exhibit 157: Merck and Co. Inc. - Key news
o Exhibit 158: Merck and Co. Inc. - Key offerings
o Exhibit 159: Merck and Co. Inc. - Segment focus
o 12.14 OK Biotech Co. Ltd.
o Exhibit 160: OK Biotech Co. Ltd. - Overview
o Exhibit 161: OK Biotech Co. Ltd. - Product / Service
o Exhibit 162: OK Biotech Co. Ltd. - Key offerings
o 12.15 Priority STD Testing
o Exhibit 163: Priority STD Testing - Overview
o Exhibit 164: Priority STD Testing - Product / Service
o Exhibit 165: Priority STD Testing - Key offerings
o 12.16 QIAGEN NV
o Exhibit 166: QIAGEN NV - Overview
o Exhibit 167: QIAGEN NV - Product / Service
o Exhibit 168: QIAGEN NV - Key news
o Exhibit 169: QIAGEN NV - Key offerings
o 12.17 RayBiotech Life Inc.
o Exhibit 170: RayBiotech Life Inc. - Overview
o Exhibit 171: RayBiotech Life Inc. - Product / Service
o Exhibit 172: RayBiotech Life Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global sexually transmitted disease (STD) testing market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Chlamydia - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Chlamydia - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Chlamydia - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Chlamydia - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Gonorrhea - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Gonorrhea - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Gonorrhea - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Gonorrhea - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Syphilis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Syphilis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Syphilis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Syphilis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Trichomoniasis - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Trichomoniasis - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Disease Type ($ million)
Exhibits55: Chart on Product - Market share 2022-2027 (%)
Exhibits56: Data Table on Product - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Product
Exhibits58: Data Table on Comparison by Product
Exhibits59: Chart on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Laboratory testing device - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Laboratory testing device - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on POC testing device - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on POC testing device - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on POC testing device - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Product ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: AccuBioTech Co. Ltd. - Overview
Exhibits120: AccuBioTech Co. Ltd. - Product / Service
Exhibits121: AccuBioTech Co. Ltd. - Key offerings
Exhibits122: AdvaCare Pharma - Overview
Exhibits123: AdvaCare Pharma - Product / Service
Exhibits124: AdvaCare Pharma - Key offerings
Exhibits125: BIOGENIX Inc. Pvt. Ltd. - Overview
Exhibits126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
Exhibits127: BIOGENIX Inc. Pvt. Ltd. - Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. - Overview
Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
Exhibits130: F. Hoffmann La Roche Ltd. - Key news
Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits133: Gilead Sciences Inc. - Overview
Exhibits134: Gilead Sciences Inc. - Product / Service
Exhibits135: Gilead Sciences Inc. - Key news
Exhibits136: Gilead Sciences Inc. - Key offerings
Exhibits137: GlaxoSmithKline Plc - Overview
Exhibits138: GlaxoSmithKline Plc - Business segments
Exhibits139: GlaxoSmithKline Plc - Key offerings
Exhibits140: GlaxoSmithKline Plc - Segment focus
Exhibits141: Hologic Inc. - Overview
Exhibits142: Hologic Inc. - Business segments
Exhibits143: Hologic Inc. - Key news
Exhibits144: Hologic Inc. - Key offerings
Exhibits145: Hologic Inc. - Segment focus
Exhibits146: Inovio Pharmaceuticals Inc. - Overview
Exhibits147: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits148: Inovio Pharmaceuticals Inc. - Key news
Exhibits149: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits150: Johnson and Johnson - Overview
Exhibits151: Johnson and Johnson - Business segments
Exhibits152: Johnson and Johnson - Key news
Exhibits153: Johnson and Johnson - Key offerings
Exhibits154: Johnson and Johnson - Segment focus
Exhibits155: Merck and Co. Inc. - Overview
Exhibits156: Merck and Co. Inc. - Business segments
Exhibits157: Merck and Co. Inc. - Key news
Exhibits158: Merck and Co. Inc. - Key offerings
Exhibits159: Merck and Co. Inc. - Segment focus
Exhibits160: OK Biotech Co. Ltd. - Overview
Exhibits161: OK Biotech Co. Ltd. - Product / Service
Exhibits162: OK Biotech Co. Ltd. - Key offerings
Exhibits163: Priority STD Testing - Overview
Exhibits164: Priority STD Testing - Product / Service
Exhibits165: Priority STD Testing - Key offerings
Exhibits166: QIAGEN NV - Overview
Exhibits167: QIAGEN NV - Product / Service
Exhibits168: QIAGEN NV - Key news
Exhibits169: QIAGEN NV - Key offerings
Exhibits170: RayBiotech Life Inc. - Overview
Exhibits171: RayBiotech Life Inc. - Product / Service
Exhibits172: RayBiotech Life Inc. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations